A comprehensive immune repertoire signature distinguishes pulmonary infiltration in SARS-CoV-2 Omicron variant infection

Front Immunol. 2024 Dec 17:15:1486352. doi: 10.3389/fimmu.2024.1486352. eCollection 2024.

Abstract

Introduction: The coronavirus disease 2019 (COVID-19) global pandemic has been the most severe public health emergency since 2019. Currently, the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the most dominant. The most prominent symptom of SARS-CoV-2 infection is respiratory. Meanwhile, the fatality of COVID-19 was mainly from pneumonia. However ,in patients with SARS-CoV-2 infection who have pneumonia and those who do not, the differences in the immune repertoire still require further investigation.

Methods: We conducted seven-chain adaptome immune repertoire analyses on patients with SARS-CoV-2 Omicron infection, both with and without pulmonary infiltration.

Results: Patients with pulmonary infiltration exhibit lymphopenia, a decreased proportion of the overall TCR repertoire alongside an increased BCR repertoire, reduced IGHD and IGHM isotype expression, a shorter mean CDR3 length for TRG, and a longer mean length for TRD, as well as diminished clonality and diversity in the TCR/BCR repertoire. Meanwhile, patients with pulmonary infiltration have distinct V-J gene usage and unique CDR3 signature, as well as BCR class switch recombination pattern. Finally, prior vaccination triggered less BCR IGHM/IGHD somatic hypermutation response, preserved the diversity of the entire adaptive immune repertoire, and provided clinical protection against severe or critical conditions following Omicron infection.

Discussion: We report a unique, comprehensive adaptive immune system signature in patients with pulmonary infiltration, which may serve as potential immunological biomarkers and therapeutic targets.

Keywords: COVID-19; SARS-CoV-2 Omicron variant; TCR; immune repertoire; vaccine.

MeSH terms

  • Adult
  • Aged
  • B-Lymphocytes / immunology
  • COVID-19* / immunology
  • Female
  • Humans
  • Lung* / immunology
  • Lung* / pathology
  • Lung* / virology
  • Lymphopenia / immunology
  • Male
  • Middle Aged
  • Receptors, Antigen, B-Cell / genetics
  • Receptors, Antigen, B-Cell / immunology
  • Receptors, Antigen, T-Cell / genetics
  • Receptors, Antigen, T-Cell / immunology
  • SARS-CoV-2* / immunology

Substances

  • Receptors, Antigen, B-Cell
  • Receptors, Antigen, T-Cell

Supplementary concepts

  • SARS-CoV-2 variants

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by a research grant from the Chinese PLA General Hospital Chronic Kidney Disease Clinical Medicine Research Centre (kfkt202015).